Feasibility and efficacy of low-dose pegfilgrastim for CD34+ cell mobilization in lymphoma.
Goto H, Hidaka D, Yamamoto S, Hayasaka K, Michimata R, Kagawa I, Sunagoya K, Iijima H, Hayase E, Shiratori S, Okada K, Sugita J, Onozawa M, Hashimoto D, Kahata K, Fujimoto K, Endo T, Shimizu C, Teshima T; North Japan Hematology Study Group (NJHSG).
Goto H, et al. Among authors: hayasaka k.
J Clin Apher. 2020 Sep;35(5):413-419. doi: 10.1002/jca.21816. Epub 2020 Jul 29.
J Clin Apher. 2020.
PMID: 33043486